Male adult germ cell tumors (GCTs) comprise two major histologic groups: seminomas and nonseminomas. Nonseminomatous GCTs (NSGCTs) can be further divided into embryonal carcinoma (EC), teratoma (T), yolk sac tumor (YS), and choriocarcinoma (CC) on the basis of the lineage differentiation that they exhibit. NSGCTs frequently present as mixed tumors consisting of two or more histological subtypes, often limiting correlative studies of clinical and molecular features to histology. We sought to develop a molecular classifier that could predict the predominant histologic subtype within mixed NSGCT tumor samples. The expression profiles of 84 NSGCTs (42 pure and 42 mixed) and normal age-matched testes were obtained using Affymetrix microarrays. Using prediction analysis for microarrays, we identified 146 transcripts that classified the histology of pure NSGCTs samples with 93% accuracy. When applied to mixed NSGCTs, the classifier predicted a histology that was consistent with one of the reported components in 93% of cases. Among the predictive transcripts were CGB (high in CC), LCN2 (high in T), BMP2 (high in YS), and POU5F1 (high in EC). Thus, the expression-based classifier accurately assigned a single predominant histology to mixed NSGCTs, and identified transcripts differentially expressed between histologic components with relevance to NSGCT differentiation.
Introduction
Germ cell tumors (GCTs) are the most common malignancy in men aged 18-35 (Bosl and Motzer, 1997) , and incidence rates are rising (Ulbright, 1993) . GCTs are broadly separated into two classes, namely, seminomas, which morphologically resemble undifferentiated germ cells, and nonseminomas. Nonseminomatous GCTs (NSGCTs) are further subdivided based on varying degrees of differentiation comparable with stages of human development (Ulbright, 1993) . Embryonal carcinomas (EC) are the least differentiated, consisting of cells that resemble pluripotent cells of primitive zygotic differentiation. Choriocarcinomas (CC), which are composed of syncytiotrophoblasts and cytotrophoblasts, exhibit extraembryonic differentiation, as do yolk sac (YS) tumors. Teratomas (Ts) display differentiation into multiple somatic lineages. Occasionally, secondary somatic malignancies can arise in association with a T, comprising primarily sarcomas, adenocarcinomas, and neuroectodermal tumors (Bosl and Motzer, 1997) . Correlative studies of clinical and molecular genetic features with GCT histology are often limited by the fact that approximately 60% of cases present as mixed tumors consisting of two or more histologic components (Mostofi et al., 2000) . Through global gene expression analysis of 84 NSGCTs, we sought to construct a robust histologic classifier, which would accurately predict the predominant histologic component within mixed NSGCTs.
Results and discussion

Gene expression profiling
Gene expression profiles of the NSGCT and normal specimens were generated using Affymetrix U133A þ B microarrays. Unsupervised hierarchical clustering was performed using 4198 transcripts that showed at least a 20-fold difference between the highest and lowest expressing samples (Figure 1 ). Partial separation of the tumor samples based on predominant histologic component was observed, as previously noted (Sperger et al., 2003) , with distinct clusters consisting of YS or T specimens evident. The EC specimens were found mainly in two clusters: EC cluster 1, which clustered with T specimens, and EC cluster 2, which clustered with YS specimens (Figure 1 ). These two clusters did not result from a predominance of pure samples in one cluster or the predominance of a specific mixed histologic subtype in the clusters. Instead, the two clusters may have arisen due to changes in expression in EC specimens associated with differentiation into T or YS lineages, which preceded morphological changes. Alternatively, the two EC clusters may reflect resection site, as 83% of the tumors in EC cluster 1 were from metastatic sites, compared to 39% in EC cluster 2. Three tumors (373A, 465A, 500A) tightly clustered with the normal testes samples (Figure 1 ). All three were primary testicular specimens, indicating potential contamination of these samples with normal tissue. Among the clusters of genes from the unsupervised clustering (Figure 1 ), the most prominent was a large set of transcripts that were strongly expressed only in normal testis, which included a number of spermspecific and spermatogenesis-related genes such as PRM1, PRM2, ZPBP, and ROPN. Similar clusters showed gene expression limited to specific histologic subtypes, including POU5F1 in EC, CGB in CC, EMP1 in T, and BMP2 in YS (Figure 1) . In T specimens, transcripts associated with neural, muscular, and pancreatic forms of somatic differentiation were observed, with the expression of the former two types also shared by several specimens with secondary somatic malignancies, consistent with transformation into neuroectodermal tumors and sarcomas (data not shown).
Expression based classification of histology
A set of 40 pure EC, YS, and T samples and three CC samples (including one mixed specimen with a reported predominant histology of CC that clustered with a pure CC; see Figure 1 ) was used to construct a classifier consisting of 146 transcripts (Supplementary Table 1 ) using prediction analysis for microarrays (PAM). The genes with the greatest predictive power in each subtype are listed in Table 1 . The classifier correctly predicted histology in 40/43 of specimens for an overall crossvalidated classification rate of 93%. PAM predicted the histology with a probability greater than 95% in all but two cases. Of the three misclassified samples, two were EC specimens that were classi fied as T (371A) and CC (411A). In case 371A, only a pattern of expression of genes predictive of T histology was evident. At the time of resection of tumor 371A, no elevation in either AFP or HCG serum levels was detected. For case 411A, there were high expression levels of CGA and HSD3B1, predictive of CC histology, and low levels of POU5F1 and NANOG, predictive of EC histology. This patient had slightly elevated serum levels of HCG. The remaining misclassi fied sample was a YS tumor, classified as an EC (303A). This sample had low levels of expression of genes that were predictive of YS histology, while most of the EC markers were expressed only at moderate levels in this sample. Misclassification of the specimens may have arisen due to alterations in gene expression that preceded morphologic changes or due to unrecognized histologic elements during pathologic review. The 146 transcript classifier was then used to predict the major histologic component in the remaining 40 mixed tumor samples and the sample with unknown histology, which was predicted to be a YS specimen. The classifier predicted a histology that was consistent with one of the reported histologic components in 37/40 mixed NSGCTs (90% CI of 81.7-97.9%), with a probability of 90% or greater in all but four cases. Of these 37, the predicted major histologic component was the same as the reported predominant subtype in 26 cases. This discrepancy may be a result of minor differences in tumor composition between the piece reviewed by H&E and the piece used for extraction of RNA. Three specimens were classified in a manner that was not consistent with the reported histology. First was an EC-T (268A) classified as a YS, likely as a result of high levels of expression of the YS marker C20orf56 and low levels of expression of EC and T markers. The respective patient did not have elevated serum marker levels at time of resection. Second was an EC-T (248A) classified as a CC, likely due to high levels of expression of CGA and CGB; at time of resection, this patient had no elevation in serum marker levels. Finally, a T with a secondary somatic malignancy (570A) was classified as an EC. There were no T predictive genes expressed at high levels, but only moderate levels of expression of EC markers were seen, with no elevation of serum marker levels.
In order to evaluate the expression of the classifier genes in all histologic subtypes, hierarchical clustering of all 84 NSGCT and the normal testes samples using these 146 transcripts was performed. The resulting dendrogram and heatmap is shown in Figure 2 . Some tumors expressed multiple transcripts predictive of different histologic subtypes, usually in a manner consistent with the reported additional components. This was exemplified by an EC,CC,T specimen (391A) which was classified as a CC on the basis of strong expression of the CC-specific genes CGA, CGB, PLAC6, LEP, HSD3B1, and TFPI. However, this sample also exhibited high levels of expression of EC predictive genes including POU5F1. Hierarchical clustering, which unlike PAM does not take gene weighting into account, resulted in clustering of this sample with other EC specimens rather than with CC specimens, since a larger number of genes in the classifier were predictive of EC histology than CC histology.
The normal testes specimens were included in this clustering to demonstrate that their expression pattern is distinct from the tumor specimens for genes included in the classifier. Of the three samples that had previously been identified as having potential normal contamination, one (373A) was still found clustered with the normal specimens, but the two other samples were found in separate clusters. Genes that have decreased expression levels that are predictive of histology Expression-based histologic classification in NSGCT JE Korkola et al Figure 2 Hierarchical clustering of tumor and normal samples using the 146 transcripts identified by PAM. Color of sample names indicates predicted histology, boxes above indicate pathologic classification of tumor sample histology (color coding is the same as in Figure 1 ). Black arrows above samples indicate pure samples that were misclassified, while blue arrows indicate mixed samples whose classification was inconsistent with pathology Expression-based histologic classification in NSGCT JE Korkola et al
Differentiation programs from classifier genes
The transcripts predictive of each histologic subset represented genes, some previously described, that were consistent with the differentiation status of the respective tumor type. Transcripts predictive of EC histology included a number of previously reported stem-cell specific genes such as POU5F1, DPPA4, and NANOG (Figure 2) , consistent with the pluripotent phenotype of EC tumors (Looijenga et al., 2003; Clark et al., 2004) . Expression of these genes was limited strictly to samples with EC components, with downregulation associated with differentiation into the extraembryonic (YS,CC) and somatic (T) lineages. In T samples, there was a large cluster of highly expressed genes specific to differentiated somatic cell lineages, including epithelial cells and connective tissue, consistent with the differentiation of these tumors into multiple somatic cell types. This cluster included the epithelial membrane protein EMP1, the connective tissue genes COL14A1, decorin (DCN), elastin (ELN), and the putative elastin associated gene MFAP4 (Zhao et al., 1995) . Interestingly, this cluster also included two transmembrane four superfamily proteins, TM4SF1 and TM4SF3, which have been found to be expressed in lung, breast, ovarian, gastric, colon, rectal, and pancreatic tumors, but not in most normal tissues (Szala et al., 1990; Marken et al., 1992) . A second cluster of genes that were predictive of T histology were downregulated in T samples and included genes that are involved in cell cycle and proliferation, such as CENPA, CDCA1, CCNB1, CDC20, and MCM5. Transcripts whose expression was restricted to CC samples included CGA, CGB, and PLAC6 (Figure 2 ), all genes that are associated with placenta and trophoblasts (Bo and Boime, 1992; Brinkmann et al., 1999) , the cell type seen in CC. Interestingly, a number of the genes that were most predictive of YS histology have been implicated in differentiation into endodermal (VTN, OTX2, BMP2, FOXA2) or mesodermal (EOMES) lineages (Cooper and Pera, 1988; Crease et al., 1998; Coucouvanis and Martin, 1999; Zakin et al., 2000; Sinner et al., 2004) . We also observed that three of the 10 most predictive genes of YS histology (C20orf56, CST1, FOXA2) mapped to 20p11, a region not previously implicated in YS tumor etiology. These results indicate that the transcripts predictive of histology are also strongly associated with lineage differentiation, showing distinct expression patterns in the different NSGCT specimens.
RT-PCR validation of expression
To validate differential expression of genes in the classifier, one gene expressed in each histological subtype was chosen for analysis by RT-PCR (Figure 3 ). Four pure samples that were profiled on the arrays were selected for each of the histological subtypes, except for CC, which had two mixed and two pure samples available. As expected, POU5F1 and NANOG were expressed predominantly in EC samples, and in the two mixed samples that were known to contain EC components. Similarly, CGB was expressed only in CC samples. LEP was expressed in three out of four of the CC samples, which agrees with the expression microarray findings. High levels of LCN2 and EMP1 expression were seen only in T samples. Finally, BMP2 was expressed mainly in YS samples, with lower levels of expression in T specimens, as was seen with the microarray results (Figure 2) . Interestingly, while CST1 expression was seen predominantly in the YS specimens as expected, there was also expression in the mixed CC samples. This suggested that there may have been a YS component in these tumors that was unrecognized during histologic evaluation. These RT-PCR results strongly support the differential gene expression identified by PAM analysis of the microarray data. The presence of two or more histologic components is an inherent feature of the majority of GCT tumors. In such mixed cases, identification of the predominant histologic subtype is desirable for correlative studies. In the present study, we have built an expression-based histologic classifier comprising 146 transcripts that predicted the major histologic component of NSGCTs. The transcript set was highly predictive of histology in both pure and mixed NSGCT specimens, indicating its potential usefulness in distinguishing mixed NSGCT tumors at the RNA level. Thus, for correlative analyses, associations within mixed NSGCTs can now be evaluated with respect to a predominant histologic subtype based on gene expression. Clinical applications of this classifier could include immunohistochemical staining of mixed GCT tumor specimens using a small panel of predictive markers for objective calls on tumor histology. In conclusion, we have identified transcripts differentially expressed between the various histologic subtypes of NSGCTs, which show a strong association with pluripotency and differentiation status in the tumors.
Materials and methods
Tumor specimens
Tumor tissues and clinical data were obtained through an IRB-approved protocol at Memorial Sloan-Kettering Cancer Center. Tumor selection was based on clinical information, availability of frozen tumor material, and review of corresponding H&E stained sections from paraffin blocks. Frozen tumor specimens were grossly microdissected in an attempt to minimize normal cell contamination. There were 84 specimens from 78 patients, which consisted of 15 pure EC, 15 pure T, 10 pure YS, two pure CC, 41 NSGCT with mixed histologies, and one specimen with unknown NSGCT histology. Specimens with one histologic diagnosis from the H&E sections were considered as pure. Six patients had two tumor specimens each, none of which clustered together and thus were treated as independent samples. Six samples contained secondary somatic malignancies. In total, 46 specimens were resected from patients previously treated with cisplatin-based chemotherapy, while 38 were from untreated patients (Table 2) . A total of 22 were primary tumors while 62 were from metastatic sites. Eight samples were of primary mediastinal presentation. For controls, five normal testis specimens from individuals of similar age to GCT patients but with no evidence of GCT, and a pool of equal amounts of RNA from these five samples were used.
RNA isolation
Frozen tumor tissue was homogenized and RNA was isolated using RNeasy midi columns (Qiagen, Valencia, CA, USA), according to the manufacturer's protocol. RNA was quantified by UV absorbance and quality was verified by A260/A280 ratios and integrity of 28S and 18S bands on denaturing agarose gels.
cDNA synthesis, labeling, and hybridization
The cDNA preparation and cRNA labeling for hybridization was performed as previously described (Houldsworth et al., 2002) . Each sample was hybridized once to each of U133A and U133B microarrays (Affymetrix, Santa Clara, CA, USA). The size of labeled cRNA was evaluated on an Agilent Bioanalyzer (Agilent, Foster City, CA, USA) to ensure probe quality for hybridization. Hybridization, washing, and imaging was performed as described previously (Houldsworth et al., 2002) .
RT-PCR expression analysis
In total, 1 mg of total RNA was reverse transcribed using 300 ng of random hexamers (Invitrogen, Carlsbad, CA, USA), dNTPs at a final concentration of 500 mM, and 100 U of superscript II reverse transcriptase (Invitrogen) at 421C. Primers were designed to span introns to distinguish between mRNA and DNA for all genes tested: POU5F1, NANOG, LCN2, EMP1, CGB, LEP, CST1, and BMP2, with ACTB as a control. PCR was carried out with 30 pmol of each primer, 20-50 ng of target cDNA, using 2.5 U PFU I turbo polymerase (Stratagene, La Jolla, CA, USA) in a total volume of 30 ml. The PCR profile was 951C for 10 min, 30 cycles of 951C for 45 s, annealing for 30 s, and extension at 721C for 45 s, followed by 5 min at 721C and a 41C hold. Annealing temperatures and primer sequences are available from the authors upon request. The product was run on 1.4% agarose gels and stained with ethidium bromide for visualization.
Data analysis
Background subtraction, normalization, and log 2 transformation of the array data were performed using robust multichip analysis (Irizarry et al., 2003) within bioconductor for R (Gentleman et al., 2004) . For histologic classification, PAM was used (Tibshirani et al., 2002) to build a classifier in pure tumor samples followed by prediction of the predominant histologic subtype in the mixed tumor samples using PAM's predict test set function. PAM ranks genes using a penalized tstatistic and uses shrinkage to select a reduced gene set for classification. The amount of shrinkage is chosen to minimize the overall cross-validated error rate. Class assignments for a given sample are made to the class with the nearest centroid. Exact binomial confidence intervals were constructed for the test set classification error. Visualization of the data was performed using the Cluster/Treeview software package (Eisen et al., 1998) . Annotation of the clones was from the 23 June 2004 update from Affymetrix.
Abbreviations GCT, germ cell tumor; NSGCT, nonseminomatous germ cell tumor; EC, embryonal carcinoma; T, teratoma; YS, yolk sac; CC, choriocarcinoma; PAM, prediction analysis for microarrays. 
